HOME >> MEDICINE >> NEWS
Timing Of Breast Cancer Surgery Doesn't Appear To Influence Survival Anymore

Is it possible that young women with breast cancer live longer if the operation to remove the cancer is performed during the middle of the menstrual cycle rather than at the beginning? The answer depends on how long ago the surgery was done. Prior to 1984, surgery done during the onset of menstruation almost doubled the risk of dying compared to surgery around the time of ovulation, according to the results of a new study led by a New York University School of Medicine researcher.

The study, led by Susan Harlap, M.D., Research Professor of Epidemiology in the Department of Obstetrics and Gynecology at NYU School of Medicine, examines the notion that timing breast cancer surgery to a particular phase of the menstrual cycle influences subsequent survival.

"This is an enormously controversial subject," says Dr. Harlap. "Our new data has shown that the timing of surgery influenced survival for women diagnosed with breast cancer in the late 1970s and early 1980s. But is it still important? We don't know, but the answer seems to be no. In the mid-1980s, something changed. From 1984 to 1988, the latest date covered by our study, the timing of surgery in the menstrual cycle has been unimportant.

"Right now we don't advocate scheduling breast cancer surgery on any particular day of the menstrual cycle," she says.

What might have changed in medical practice? Harlap points out that not only have surgical practice and chemotherapy changed, but so also have the drugs used for the anesthetic, as well as for post-operative pain control. "Patients are now kept warmer during the operation, fewer need blood transfusions and infection control has improved," she says. Harlap and her colleagues speculate that any one of these changes may have benefited breast cancer patients, as they are known to influence survival in other kinds of cancer.

Some previous studies have shown that surgery during the first half of
'"/>

Contact: Marjorie Shaffer
Marjorie.Shaffer@med.nyu.edu
212.263.5488
New York University Medical Center and School of Medicine
30-Jun-1998


Page: 1 2

Related medicine news :

1. Timing appears essential to combining antiangiogenesis and radiation therapy
2. Timing of adverse events in hospital patients
3. Hausman to give keynote address at Breastfeeding, Motherhood and Feminism symposium
4. Breast implant Website launched by leading plastic surgery societies
5. Breast cancer treatment reduces risk of heart disease
6. Breast reconstruction with implants after mastectomy doesnt hurt survival chances
7. Breast cancer may be uniquely sensitive to inhibitors of PI3K pathway
8. Breast MRI moderately useful for detecting breast cancer, but does not eliminate need for biopsy
9. Breast conserving therapy safe for hereditary breast cancer
10. Breast cancer risk, prognosis and weight gain reduced with physical activity
11. Breast cancer in Asian Americans is rising faster than in any other ethnic group

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/20/2017)... 20, 2017 (PRWEB) , ... ... ... a global provider of enterprise-grade IT operations analytics and application performance monitoring ... one of world’s largest healthcare services providers. , According to Peter Ohrenberger, ...
(Date:7/20/2017)... ... ... Doctors on Liens, the leading network of medical providers working on a ... Russell Horine, DC to their exclusive list of medical professionals. Horine Chiropractic is a ... the clinic director and his son Dr. Lee Horine and daughter-in-law Dr. Natalie Horine ...
(Date:7/20/2017)... ... July 20, 2017 , ... TCGRx announced today ... existing adherence automation lines. The ATP® Mini and InspectRx® Mini are ... standard products, but at a size and price point that can help pharmacies ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... LINET, an ... latest innovation to their product line: the AVE 2 birthing bed. , Perfectly suitable ... bring a new level of comfort and efficiency to every phase of childbirth. The ...
(Date:7/20/2017)... ... July 19, 2017 , ... ... million Health Resources and Services Administration (HRSA) grant to train predoctoral dental students ... care needs in rural and underserved areas. , The Predoctoral Pediatric Training Project ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... , July 11, 2017  The global market for ... of approximately $394.1 million in 2016.  Although in early ... solid growth, in particular as a result of the ... and the recent introduction of a significant number of ... less-invasive testing of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
(Date:7/10/2017)... S.C. , July 10, 2017  BDI ... purchasing and patient support services organization serving specialty ... today the launch of four significant, value-added member ... market insights, better manage reimbursement and improve access ... and factor therapies. ...
Breaking Medicine Technology:
Cached News: